Janux Therapeutics, Inc. ( JANX) - Key Metrics
JANX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0.16 | -$0.39 | -$0.21 | -$0.21 |
| 2025Q2 | ? | -$0.55 | -$0.38 | -$0.39 |
| 2025Q1 | ? | -$0.38 | -$0.28 | -$0.28 |
JANX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -15.59 |
| 2025Q2 | ? | -10.56 |
| 2025Q1 | ? | -17.74 |
JANX
Price: $15.33
52 week price:
Earnings Per Share: -1.84 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 219876
Market Capitalization: 947.7 million